As of 2025-09-16, the Fair Value of Akero Therapeutics Inc (AKRO) is -17.75 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 42.85 USD, the upside of Akero Therapeutics Inc is -141.42%.
With the market price of 42.85 USD and our fair value calculation, Akero Therapeutics Inc (AKRO) is not a good investment. Investing in AKRO stocks now will result in a potential loss of 141.42%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -79.21 | -100.78 | -112.03 | -151.76 | -252.06 | -139.17 |
| YoY growth | -81.01% | -27.23% | -11.16% | -35.46% | -66.09% | -44.19% |
| Market Cap (mil) | 3,427.57 |
| P/E | |
| Forward P/E |
| EPS | -3.55 |
| Avg earnings growth rate | -44.19% |
| TTM earnings | -283.96 |